Arrowstreet Capital’s Viemed Healthcare VMD Stock Holding History

Arrowstreet Capital’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9.5M	Buy	1,043,664 +257,395	+33%	+$2.6M	﹤0.01%	1053
2026 Q2	$8.96M	Buy	786,269 +75,083	+11%	+$743K	﹤0.01%	1113
2026 Q1	$6.55M	Buy	711,186 +358,863	+102%	+$2.99M	﹤0.01%	1073
2025 Q4	$2.62M	Hold	352,323	–	–	﹤0.01%	1329
2025 Q3	$2.39M	Buy	352,323 +118,589	+51%	+$803K	﹤0.01%	1409
2025 Q2	$1.62M	Hold	233,734	–	–	﹤0.01%	1503
2025 Q1	$1.7M	Buy	233,734 +40,638	+21%	+$319K	﹤0.01%	1344
2024 Q4	$1.55M	Buy	+193,096	New	+$1.68M	﹤0.01%	1349
2024 Q1	–	Sell	-126,066	Closed	-$990K	–	1783
2023 Q4	$990K	Sell	126,066 -81,741	-39%	-$593K	﹤0.01%	1103
2023 Q3	$1.4M	Sell	207,807 -63,440	-23%	-$520K	﹤0.01%	919
2023 Q2	$2.66M	Buy	+271,247	New	+$2.75M	﹤0.01%	760
2020 Q4	–	Sell	-10,400	Closed	-$90K	–	2558
2020 Q3	$90K	Buy	+10,400	New	+$105K	﹤0.01%	2260
2020 Q1	–	Sell	-27,500	Closed	-$172K	–	2138
2019 Q4	$172K	Buy	+27,500	New	+$191K	﹤0.01%	1630

Other funds holding VMD

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return

Martin & Co Knoxville, Tennessee $616M AUM 16.64% 1-Year Est. Return

Panagora Asset Management Boston, Massachusetts $33.2B AUM 43.67% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Arrowstreet Capital's VMD Position: Q3 2026 in Review

Arrowstreet Capital increased its Viemed Healthcare (VMD) stake by 33% in Q3 2026, buying an estimated $2.6M and bringing the position to 1,043,664 shares worth $9.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1053.

Arrowstreet Capital first reported a position in VMD in Q4 2019 and has held it in 13 quarters since. 117 funds tracked by Wall St. Rank hold VMD as of Q3 2026.

Arrowstreet Capital held 1,043,664 shares of Viemed Healthcare worth $9.5M as of Q3 2026.
Arrowstreet Capital bought 257,395 Viemed Healthcare shares in Q3 2026, an estimated $2.6M.
Viemed Healthcare made up ﹤0.01% of Arrowstreet Capital's portfolio in Q3 2026, its #1053 holding.
Arrowstreet Capital first reported a position in Viemed Healthcare in Q4 2019 and has held it in 13 quarters since.
117 funds tracked by Wall St. Rank held Viemed Healthcare as of Q3 2026.

Based on Arrowstreet Capital's 13F filing for Q3 2026, filed 13 Nov 2026.